Drug Type Interferons, Biosimilar |
Synonyms Fu Li Sheng, 复力生 |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Basal Cell Carcinoma | CN | - | |
Condylomata Acuminata | CN | - | |
Hairy Cell Leukemia | CN | - | |
Hepatitis B, Chronic | CN | - | |
Hepatitis C | CN | - | |
Hepatitis D | CN | - | |
Herpes Zoster | CN | - | |
Kaposi Sarcoma | CN | - | |
Laryngeal Papillomatosis | CN | - | |
Melanoma | CN | - | |
Multiple Myeloma | CN | - | |
Ovarian Cancer | CN | - | |
Philadelphia chromosome positive chronic myelogenous leukemia | CN | - |